[go: up one dir, main page]

AR110000A1 - Sistema de inmunoensayo con la capacidad de sugerir análisis en base a datos de entrada - Google Patents

Sistema de inmunoensayo con la capacidad de sugerir análisis en base a datos de entrada

Info

Publication number
AR110000A1
AR110000A1 ARP170103006A ARP170103006A AR110000A1 AR 110000 A1 AR110000 A1 AR 110000A1 AR P170103006 A ARP170103006 A AR P170103006A AR P170103006 A ARP170103006 A AR P170103006A AR 110000 A1 AR110000 A1 AR 110000A1
Authority
AR
Argentina
Prior art keywords
analysis
user interface
capacity
test system
analysis based
Prior art date
Application number
ARP170103006A
Other languages
English (en)
Inventor
Cleve Mark David Van
Original Assignee
Hycor Biomedical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hycor Biomedical Llc filed Critical Hycor Biomedical Llc
Publication of AR110000A1 publication Critical patent/AR110000A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0098—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F9/00—Arrangements for program control, e.g. control units
    • G06F9/06—Arrangements for program control, e.g. control units using stored programs, i.e. using an internal store of processing equipment to receive or retain programs
    • G06F9/44—Arrangements for executing specific programs
    • G06F9/451—Execution arrangements for user interfaces
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/10—Analysis or design of chemical reactions, syntheses or processes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Theoretical Computer Science (AREA)
  • Software Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Computing Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Human Computer Interaction (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Métodos y aparato para realizar análisis de diagnostico utilizando recomendaciones en base a una o más entradas de datos. En una forma de realización, un sistema para diagnosticar y ensayar una o más enfermedades en un paciente incluye un aparato de análisis configurado para realizar una pluralidad de análisis diferentes en una muestra del paciente utilizando una pluralidad de reactivos de captura almacenados, una interfaz de usuario en comunicación operativa con el aparato de análisis, la interfaz de usuario configurada para permitir ingresar unos síntomas del paciente, y una unidad de control en comunicación operativa con la interfaz de usuario, la unidad de control configurada para (i) analizar una base de datos con perfiles de enfermedades en base a los síntomas ingresados en la interfaz de usuario, (ii) producir la salida de por lo menos un análisis recomendado en base a los análisis de la base de datos con perfiles de enfermedades, y (iii) hacer que el aparato de análisis realice el por lo menos un análisis utilizando por lo menos uno de la pluralidad de reactivos de captura.
ARP170103006A 2016-11-01 2017-10-30 Sistema de inmunoensayo con la capacidad de sugerir análisis en base a datos de entrada AR110000A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662415876P 2016-11-01 2016-11-01

Publications (1)

Publication Number Publication Date
AR110000A1 true AR110000A1 (es) 2019-02-13

Family

ID=62076135

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170103006A AR110000A1 (es) 2016-11-01 2017-10-30 Sistema de inmunoensayo con la capacidad de sugerir análisis en base a datos de entrada

Country Status (10)

Country Link
US (1) US20200057083A1 (es)
EP (1) EP3535584A4 (es)
JP (1) JP7069151B2 (es)
KR (1) KR20190079651A (es)
CN (1) CN110168365A (es)
AR (1) AR110000A1 (es)
AU (1) AU2017355347A1 (es)
SG (1) SG11201903627VA (es)
TW (1) TW201832726A (es)
WO (1) WO2018085151A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6389868B2 (ja) 2013-03-15 2018-09-12 ジーピービー デット ホールディングス トゥー エルエルシー サンプルの発光及び蛍光測定を行うための装置及び関連する方法
US10196678B2 (en) 2014-10-06 2019-02-05 ALVEO Technologies Inc. System and method for detection of nucleic acids
JP2018510354A (ja) 2015-03-30 2018-04-12 ハイコア バイオメディカル エルエルシー 自己免疫および感染性疾患の診断アッセイを実施するための自動免疫分析システム
CN109996888A (zh) 2016-09-23 2019-07-09 阿尔韦奥科技公司 用于检测分析物的方法和组合物
TWI766942B (zh) * 2017-02-13 2022-06-11 美商海科生醫有限責任公司 透過利用瞬態和穩態間隔振動移液管來混合流體或介質的設備和方法
WO2020132008A1 (en) * 2018-12-20 2020-06-25 Alveo Technologies, Inc. Handheld impedance-based diagnostic test system for detecting analytes
US12472492B2 (en) 2020-08-14 2025-11-18 Alveo Technologies, Inc. Systems and methods of sample depositing and testing
US20240428905A1 (en) * 2020-10-25 2024-12-26 Assaya Llc Centralized medical test hub

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049319A1 (en) 1998-03-25 1999-09-30 Oestergaard Steen Micro system and method for field manipulation of particles
US6383135B1 (en) * 2000-02-16 2002-05-07 Oleg K. Chikovani System and method for providing self-screening of patient symptoms
US7379885B1 (en) 2000-03-10 2008-05-27 David S. Zakim System and method for obtaining, processing and evaluating patient information for diagnosing disease and selecting treatment
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
US20050065813A1 (en) 2003-03-11 2005-03-24 Mishelevich David J. Online medical evaluation system
US8741565B2 (en) 2005-12-30 2014-06-03 Honeywell International Inc. Oligonucleotide microarray for identification of pathogens
JP4969293B2 (ja) * 2007-03-30 2012-07-04 シスメックス株式会社 検体分析装置
US8222048B2 (en) 2007-11-05 2012-07-17 Abbott Laboratories Automated analyzer for clinical laboratory
WO2012051386A2 (en) 2010-10-14 2012-04-19 Meso Scale Technologies, Llc Reagent storage in an assay device
CN103314383A (zh) * 2010-11-01 2013-09-18 皇家飞利浦电子股份有限公司 包括专有测试的特许使用费的自动化代理的体外诊断测试
KR102047141B1 (ko) 2011-01-20 2019-11-20 이뮤노사이언시스 랩. 인크. 글루텐 과민성 검출 및 만성소화장애증과의 구별 방법 및 장치
JP6389868B2 (ja) 2013-03-15 2018-09-12 ジーピービー デット ホールディングス トゥー エルエルシー サンプルの発光及び蛍光測定を行うための装置及び関連する方法
WO2015031542A1 (en) * 2013-08-27 2015-03-05 Bioneur, Llc Systems and methods for rare disease prediction
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
US20160224730A1 (en) * 2015-01-30 2016-08-04 RGA International Corporation Devices and methods for diagnostics based on analysis of nucleic acids
JP2018510354A (ja) 2015-03-30 2018-04-12 ハイコア バイオメディカル エルエルシー 自己免疫および感染性疾患の診断アッセイを実施するための自動免疫分析システム
AU2016294420B2 (en) * 2015-07-15 2019-04-18 Hycor Biomedical, Llc Customizable instrument
EP3344804A4 (en) 2015-09-03 2019-08-28 Becton, Dickinson and Company METHOD AND SYSTEMS FOR PROVIDING MARKED BIOMOLECULES
JP7084695B2 (ja) 2017-03-28 2022-06-15 シスメックス株式会社 試薬選択支援装置、方法、プログラムおよび記録媒体並びに試料測定装置

Also Published As

Publication number Publication date
TW201832726A (zh) 2018-09-16
AU2017355347A1 (en) 2019-05-02
KR20190079651A (ko) 2019-07-05
JP7069151B2 (ja) 2022-05-17
SG11201903627VA (en) 2019-05-30
US20200057083A1 (en) 2020-02-20
EP3535584A4 (en) 2020-05-06
JP2019537717A (ja) 2019-12-26
EP3535584A1 (en) 2019-09-11
WO2018085151A1 (en) 2018-05-11
CN110168365A (zh) 2019-08-23

Similar Documents

Publication Publication Date Title
AR110000A1 (es) Sistema de inmunoensayo con la capacidad de sugerir análisis en base a datos de entrada
AR102615A1 (es) Analizador de analitos
MX368046B (es) Sistemas para medir propiedades de agua en un sistema de distribucion de agua.
MX2021005882A (es) Sistemas y metodos para determinar defectos en objetos fisicos.
CO2019014515A2 (es) Métodos y sistemas para la gestión de la integridad del pozo
MX2018004367A (es) Sistema de ensayo de baterias para predecir los resultados del ensayo de baterias.
MX2022001727A (es) Sistemas y metodos para recolectar y transmitir resultados de ensayos.
AR092378A1 (es) Sistema de recomendacion agricola dirigida
MX2017008904A (es) Biomarcadores basados en sangre para diagnosticar enfermedad de arteria coronaria ateroesclerotica.
WO2014150306A8 (en) System and method for coordinating field user testing results for a mobile application across various mobile devices
WO2015157407A8 (en) Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment
BR112019006879A2 (pt) sistema de análise e método para testagem de uma amostra
MX2016013984A (es) Sistema y metodo de deteccion de hemolisis.
MX2017014196A (es) Deteccion de factores de virulencia microbiana bucal.
BR112018007841A2 (pt) métodos e sistema de processamento de dados ópticos.
GB2545850A (en) System and method using a combined modality optical probe
GB2546666A (en) Optical computing device diagnostics and treatment
MX2020005175A (es) Interfaz de usuario, para gestionar un entorno multiple de motores de diagnostico.
AR105379A1 (es) Dispositivo para detectar proteínas mal plegadas y sus métodos de uso
EP3725233A4 (en) ULTRASONIC DIAGNOSTIC DEVICE AND CONTROL PROCEDURE FOR IT
MX2019014311A (es) Sistema y metodo para la identificacion y navegacion de objetos anatomicos utilizando redes de aprendizaje profundo.
JP2016519408A5 (es)
CY1122873T1 (el) Διαγνωστικη δοκιμη για την ανοσολογικη τροφικη ευαισθησια σε κυνας
Martínez et al. Is there any evidence for the validity of diagnostic criteria used for accommodative and nonstrabismic binocular dysfunctions?
CN103631082B (zh) 一种单反相机手柄测试制具系统

Legal Events

Date Code Title Description
FB Suspension of granting procedure